SYMPTOMATIC DERMOGRAPHISM
Clinical trials for SYMPTOMATIC DERMOGRAPHISM explained in plain language.
Never miss a new study
Get alerted when new SYMPTOMATIC DERMOGRAPHISM trials appear
Sign up with your email to follow new studies for SYMPTOMATIC DERMOGRAPHISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for Long-Term control of chronic hives
Disease control TerminatedThis study is testing the long-term safety and effectiveness of a drug called briquilimab for people with chronic hives. It includes 67 participants who have already completed a previous trial with the same drug. The goal is to see if briquilimab remains safe and helps control hi…
Matched conditions: SYMPTOMATIC DERMOGRAPHISM
Phase: PHASE2 • Sponsor: Jasper Therapeutics, Inc. • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Experimental shot for Cold-Triggered hives tested, but trial stopped early
Symptom relief TerminatedThis early-stage trial tested a single dose of a drug called briquilimab in 27 adults with chronic hives caused by cold or friction that did not improve with standard allergy pills. The main goal was to check safety and see if the drug could reduce symptoms. However, the trial wa…
Matched conditions: SYMPTOMATIC DERMOGRAPHISM
Phase: PHASE1, PHASE2 • Sponsor: Jasper Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC